Global Gene Sysnthesis Market - Forecasts from 2019 to 2024
The global gene synthesis market was valued at US$1,270.605 million in 2018 and is anticipated to grow at a CAGR of 22.03% to reach a market size of US$4,195.754 million by 2024. Gene synthesis refers to the chemical, base-by-base in vitro synthesis of double-stranded DNA sequence that represents one or more genes. The technology has become a significant tool in the areas of vaccine development, gene therapy, molecular engineering, and in development of recombinant DNA. Gene synthesis has also introduced the possibility of developing genes containing modified nucleotides or even novel base pairs that could allow for the expansion of the genetic code. The growth in the market may be attributed to the increasing investment in research and development in the field of genomics and next-generation sequencing. Increasing interest and funding in the field of genomics will also positively impact the market. However, the high cost and complexity of the gene synthesis techniques might hamper the growth of the market in the forecast period. Additionally, the dearth of skilled professionals might also restrain the market for gene synthesis during the given time frame.
The Global Gene Synthesis Market – Forecasts from 2019 to 2024 is an exhaustive study which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, by application, by end-user and by geography.
The global gene synthesis market has been segmented based on type, application, end-user, and geography. On the basis of type, the market has been segmented into gene library synthesis and custom gene synthesis. On the basis of application, the market is categorized into synthetic biology, genetic engineering, vaccine design, therapeutic antibodies, and others. On the basis of end-user, the market is categorized into pharmaceutical and biopharmaceutical companies, contract research organizations, and research institutes.
Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa (MEA), and the Asia Pacific regions. The report also analyzes 16 major countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the global gene synthesis market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the global gene synthesis market.
Segmentation:
The Global Gene Synthesis Market – Forecasts from 2019 to 2024 is an exhaustive study which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, by application, by end-user and by geography.
The global gene synthesis market has been segmented based on type, application, end-user, and geography. On the basis of type, the market has been segmented into gene library synthesis and custom gene synthesis. On the basis of application, the market is categorized into synthetic biology, genetic engineering, vaccine design, therapeutic antibodies, and others. On the basis of end-user, the market is categorized into pharmaceutical and biopharmaceutical companies, contract research organizations, and research institutes.
Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa (MEA), and the Asia Pacific regions. The report also analyzes 16 major countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the global gene synthesis market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the global gene synthesis market.
Segmentation:
- By Type
- Gene Library Synthesis
- Custom Gene Synthesis
- By Application
- Synthetic Biology
- Genetic Engineering
- Vaccine Design
- Therapeutic Antibodies
- Others
- By End-User
- Pharmaceutical and Biopharmaceutical Companies
- Contract Research Organizations
- Research Institutes
- By Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- Germany
- France
- United Kingdom
- Spain
- Others
- Middle East and Africa
- Saudi Arabia
- Israel
- UAE
- Others
- Asia Pacific
- China
- Japan
- South Korea
- India
- Others
1. INTRODUCTION
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. GLOBAL GENE SYNTHESIS MARKET ANALYSIS, BY TYPE
5.1. Introduction
5.2. Gene Library Synthesis
5.3. Custom Gene Synthesis
6. GLOBAL GENE SYNTHESIS MARKET ANALYSIS, BY APPLICATION
6.1. Introduction
6.2. Synthetic Biology
6.3. Genetic Engineering
6.4. Vaccine Design
6.5. Therapeutic Antibodies
6.6. Others
7. GLOBAL GENE SYNTHESIS MARKET ANALYSIS, BY END-USER
7.1. Introduction
7.2. Pharmaceutical and Biopharmaceutical Companies
7.3. Contract Research Organizations
7.4. Research Institutes
8. GLOBAL GENE SYNTHESIS MARKET ANALYSIS, BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. North America gene synthesis Market, By Type, 2018 to 2024
8.2.2. North America gene synthesis Market, By Application, 2018 to 2024
8.2.3. North America gene synthesis Market, By End-User, 2018 to 2024
8.2.4. By Country
8.2.4.1. USA
8.2.4.1.1. By Type
8.2.4.1.2. By Application
8.2.4.1.3. By End-User
8.2.4.2. Canada
8.2.4.2.1. By Type
8.2.4.2.2. By Application
8.2.4.2.3. By End-User
8.2.4.3. Mexico
8.2.4.3.1. By Type
8.2.4.3.2. By Application
8.2.4.3.3. By End-User
8.3. South America
8.3.1. South America gene synthesis Market, By Type, 2018 to 2024
8.3.2. South America gene synthesis Market, By Application, 2018 to 2024
8.3.3. South America gene synthesis Market, By End-User, 2018 to 2024
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.1.1. By Type
8.3.4.1.2. By Application
8.3.4.1.3. By End-User
8.3.4.2. Argentina
8.3.4.2.1. By Type
8.3.4.2.2. By Application
8.3.4.2.3. By End-User
8.3.4.3. Others
8.4. Europe
8.4.1. Europe gene synthesis Market, By Type, 2018 to 2024
8.4.2. Europe gene synthesis Market, By Application, 2018 to 2024
8.4.3. Europe gene synthesis Market, By End-User, 2018 to 2024
8.4.4. By Country
8.4.4.1. Germany
8.4.4.1.1. By Type
8.4.4.1.2. By Application
8.4.4.1.3. By End-User
8.4.4.2. France
8.4.4.2.1. By Type
8.4.4.2.2. By Application
8.4.4.2.3. By End-User
8.4.4.3. United Kingdom
8.4.4.3.1. By Type
8.4.4.3.2. By Application
8.4.4.3.3. By End-User
8.4.4.4. Spain
8.4.4.4.1. By Type
8.4.4.4.2. By Application
8.4.4.4.3. By End-User
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. Middle East and Africa gene synthesis Market, By Type, 2018 to 2024
8.5.2. Middle East and Africa gene synthesis Market, By Application, 2018 to 2024
8.5.3. Middle East and Africa gene synthesis Market, By End-User, 2018 to 2024
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.1.1. By Type
8.5.4.1.2. By Application
8.5.4.1.3. By End-User
8.5.4.2. Israel
8.5.4.2.1. By Type
8.5.4.2.2. By Application
8.5.4.2.3. By End-User
8.5.4.3. UAE
8.5.4.3.1. By Type
8.5.4.3.2. By Application
8.5.4.3.3. By End-User
8.5.4.4. Others
8.6. Asia Pacific
8.6.1. Asia Pacific gene synthesis Market, By Type, 2018 to 2024
8.6.2. Asia Pacific gene synthesis Market, By Application, 2018 to 2024
8.6.3. Asia Pacific gene synthesis Market, By End-User, 2018 to 2024
8.6.4. By Country
8.6.4.1. China
8.6.4.1.1. By Type
8.6.4.1.2. By Application
8.6.4.1.3. By End-User
8.6.4.2. Japan
8.6.4.2.1. By Type
8.6.4.2.2. By Application
8.6.4.2.3. By End-User
8.6.4.3. South Korea
8.6.4.3.1. By Type
8.6.4.3.2. By Application
8.6.4.3.3. By End-User
8.6.4.4. India
8.6.4.4.1. By Type
8.6.4.4.2. By Application
8.6.4.4.3. By End-User
8.6.4.5. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.1. Thermo Fisher Scientific Inc.
10.2. GENEWIZ
10.3. GenScript
10.4. Eurofins Genomics
10.5. ATUM
10.6. Synbio Technologies
10.7. Epoch Life Science Inc.
10.8. GCC Biotech (India) Pvt. Ltd
10.9. Evonetix
10.10. Twist Bioscience Corporation
11. APPENDIX
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. GLOBAL GENE SYNTHESIS MARKET ANALYSIS, BY TYPE
5.1. Introduction
5.2. Gene Library Synthesis
5.3. Custom Gene Synthesis
6. GLOBAL GENE SYNTHESIS MARKET ANALYSIS, BY APPLICATION
6.1. Introduction
6.2. Synthetic Biology
6.3. Genetic Engineering
6.4. Vaccine Design
6.5. Therapeutic Antibodies
6.6. Others
7. GLOBAL GENE SYNTHESIS MARKET ANALYSIS, BY END-USER
7.1. Introduction
7.2. Pharmaceutical and Biopharmaceutical Companies
7.3. Contract Research Organizations
7.4. Research Institutes
8. GLOBAL GENE SYNTHESIS MARKET ANALYSIS, BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. North America gene synthesis Market, By Type, 2018 to 2024
8.2.2. North America gene synthesis Market, By Application, 2018 to 2024
8.2.3. North America gene synthesis Market, By End-User, 2018 to 2024
8.2.4. By Country
8.2.4.1. USA
8.2.4.1.1. By Type
8.2.4.1.2. By Application
8.2.4.1.3. By End-User
8.2.4.2. Canada
8.2.4.2.1. By Type
8.2.4.2.2. By Application
8.2.4.2.3. By End-User
8.2.4.3. Mexico
8.2.4.3.1. By Type
8.2.4.3.2. By Application
8.2.4.3.3. By End-User
8.3. South America
8.3.1. South America gene synthesis Market, By Type, 2018 to 2024
8.3.2. South America gene synthesis Market, By Application, 2018 to 2024
8.3.3. South America gene synthesis Market, By End-User, 2018 to 2024
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.1.1. By Type
8.3.4.1.2. By Application
8.3.4.1.3. By End-User
8.3.4.2. Argentina
8.3.4.2.1. By Type
8.3.4.2.2. By Application
8.3.4.2.3. By End-User
8.3.4.3. Others
8.4. Europe
8.4.1. Europe gene synthesis Market, By Type, 2018 to 2024
8.4.2. Europe gene synthesis Market, By Application, 2018 to 2024
8.4.3. Europe gene synthesis Market, By End-User, 2018 to 2024
8.4.4. By Country
8.4.4.1. Germany
8.4.4.1.1. By Type
8.4.4.1.2. By Application
8.4.4.1.3. By End-User
8.4.4.2. France
8.4.4.2.1. By Type
8.4.4.2.2. By Application
8.4.4.2.3. By End-User
8.4.4.3. United Kingdom
8.4.4.3.1. By Type
8.4.4.3.2. By Application
8.4.4.3.3. By End-User
8.4.4.4. Spain
8.4.4.4.1. By Type
8.4.4.4.2. By Application
8.4.4.4.3. By End-User
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. Middle East and Africa gene synthesis Market, By Type, 2018 to 2024
8.5.2. Middle East and Africa gene synthesis Market, By Application, 2018 to 2024
8.5.3. Middle East and Africa gene synthesis Market, By End-User, 2018 to 2024
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.1.1. By Type
8.5.4.1.2. By Application
8.5.4.1.3. By End-User
8.5.4.2. Israel
8.5.4.2.1. By Type
8.5.4.2.2. By Application
8.5.4.2.3. By End-User
8.5.4.3. UAE
8.5.4.3.1. By Type
8.5.4.3.2. By Application
8.5.4.3.3. By End-User
8.5.4.4. Others
8.6. Asia Pacific
8.6.1. Asia Pacific gene synthesis Market, By Type, 2018 to 2024
8.6.2. Asia Pacific gene synthesis Market, By Application, 2018 to 2024
8.6.3. Asia Pacific gene synthesis Market, By End-User, 2018 to 2024
8.6.4. By Country
8.6.4.1. China
8.6.4.1.1. By Type
8.6.4.1.2. By Application
8.6.4.1.3. By End-User
8.6.4.2. Japan
8.6.4.2.1. By Type
8.6.4.2.2. By Application
8.6.4.2.3. By End-User
8.6.4.3. South Korea
8.6.4.3.1. By Type
8.6.4.3.2. By Application
8.6.4.3.3. By End-User
8.6.4.4. India
8.6.4.4.1. By Type
8.6.4.4.2. By Application
8.6.4.4.3. By End-User
8.6.4.5. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.1. Thermo Fisher Scientific Inc.
10.2. GENEWIZ
10.3. GenScript
10.4. Eurofins Genomics
10.5. ATUM
10.6. Synbio Technologies
10.7. Epoch Life Science Inc.
10.8. GCC Biotech (India) Pvt. Ltd
10.9. Evonetix
10.10. Twist Bioscience Corporation
11. APPENDIX
